Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID
- Deep Vein Thrombosis
- Pulmonary Embolism
- Thrombosis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Multicenter randomized (1:1) controlled open-label trial, stratified on disease severity (admission to ICU or not)Masking: Single (Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04373707
- Collaborators
- Ministry of Health, France
- Grand Est Region
- University Hospital of Saint-Etienne
- Investigators
- Study Director: El Mehdi Siaghy Research and Innovation Department, Nancy University Hospital Principal Investigator: Stéphane Zuily, MD, PhD Nancy Academic Hospital